HOXA9和CD163可以增强胰腺管道腺癌的进展
Aiat Shaban Hemida1, Mohamed Mohamady Ahmed2, Mona Saeed Tantawy3
1Pathology Department, Faculty of Medicine, Menoufia University, Yassin Abd Elghafar Street, Shibin El Kom, Menoufia, 32511, Egypt. Ayat.Hameda@med.menofia.edu.eg.
Diagnostic pathology
|October 27, 2024
概括
通过吸引与瘤相关的巨细胞,HOXA9和CD163促进胰腺癌的进展. 高水平的HOXA9和CD163与胰腺管腺癌 (PDAC) 患者的预后不佳和生存时间缩短有关.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 胰腺管道腺癌 (PDAC) 的进展受到HOXA9和瘤相关巨细胞 (TAMs) 的影响.
- HOXA9可能会吸引表达CD163的TAM,从而影响PDAC的预后.
- 鉴于正在进行的HOXA9抑制剂开发,研究HOXA9和CD163表达是至关重要的.
研究的目的:
- 研究HOXA9和CD163在胰腺管道腺癌 (PDAC) 进展中的表达和临床相关性.
- 确定HOXA9,CD163和PDAC中的临床病理特征之间的相关性.
- 在PDAC患者中评估HOXA9和CD163的预后价值.
主要方法:
- 针对HOXA9和CD163的免疫组织化学染色对98个PDAC组织和98个邻近的非瘤对照进行了.
- 对HOXA9和CD163.3的染色强度,百分比和H分数进行定量分析.
- 统计分析以将标记物表达与临床病理参数和患者存活率相关联.
主要成果:
- 与对照组相比,PDAC组织的HOXA9和CD163表达显著更高.
- HOXA9和CD163表达水平与较大的瘤大小,较高的组织学等级和高级阶段显著相关.
- 高的HOXA9和CD163表达与较差的整体存活率相关,CD163被确定为独立的预后标志物.
结论:
- 通过促进CD163表达TAMs的吸引力,HOXA9可能会增强PDAC的进展.
- 在PDAC中,HOXA9和CD163显示出作为治疗标和预后生物标记物的潜力.
- 较高的HOXA9和CD163水平预测PDAC患者的预后更差,生存时间更短.
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K